Martin Fromm#
| Membership Number: | 6912 |
| Membership type: | ORDINARY |
| Section: | CLINICAL & VETERINARY SCIENCE |
| Elected: | 2024 |
| Main Country of Residence: | GERMANY |
| Homepage(s): | https://www.pharmakologie.med.fau.de |
| ORCID: | 0000-0002-0334-7478 |
| Linkedin: | https://www.linkedin.com/in/prof-dr-martin-f-fromm-5675a72b2 |
Present and Previous Positions
- 2004 - present Director, Institute of Experimental and Clinical Pharmacology and Toxicology, University Erlangen-Nürnberg
- 2004 - present Chair, Professor of Clinical Pharmacology and Clinical Toxicology at University Erlangen-Nürnberg
- 2002 - 2004 (Acting) Professor of Clinical Pharmacology and Clinical Toxicology at University Erlangen-Nürnberg
- 1999 - 2002 Group leader at the Dr. Margarete-Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
- 1997 - 1999 Postdoctoral fellow at the Division of Clinical Pharmacology, Vanderbilt University, Nashville, USA
- 1992 - 1996 Postdoctoral fellow at the Dr. Margarete-Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
Fields of Scholarship
- Biomarkers for transporter-mediated drug-drug interactions
- Medication safety (oncology, geriatrics)
- Mass spectrometry and metabolomics
- Drug transporters and drug metabolism
- Mechanisms underlying drug-drug interactions
Honours and Awards
- 2024 Top 3% Highly Cited Researcher, AD Scientific Index
- 2023 Top 2% Highly Cited Researcher, Stanford List (Ioannidis et al.)
- 2023 Top 3% Highly Cited Researcher, AD Scientific Index
- 2022 Top 3% Highly Cited Researcher, AD Scientific Index
- 2021 MSD Health Award
- 2016 Highly Cited Researcher in Pharmacology & Toxicology, Clarivate Analytics
- 2015 Erlangen Award for Medicine, Technology and Health
- 2015 Highly Cited Researcher in Pharmacology & Toxicology, Clarivate Analytics
- 2001 Paul-Martini-Award, Paul-Martini-Foundation
- 1998 Presidential Trainee Award, American Society for Clinical Pharmacology and Therapeutics
- 1997 - 1999 Fellowship of the German Research Council (DFG)
